Clinical trial
Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum…
NCT00252226 · Mood Disorders Center of Ottawa, Other · Completed
Key facts
| NCT number | NCT00252226 |
|---|---|
| Title | Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders |
| Official title | Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders: An Open Prospective Longitudinal Study of the Effectiveness of Quetiapine Monotherapy in Preventing Relapse and Minimizing Neurocognitive Dysfunction Among Adolescents Manifesting Bipolar Spectrum Disorders |
| Lead sponsor | Mood Disorders Center of Ottawa, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine |
| Enrollment | 100 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 11, 2005 |
| Last update posted | Jun 4, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: